patent/PH-12014502325-A1

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PH-12014502325-A1

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_143ac4fbe1e063c6a828a96cfffc34d5
classificationCPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-10
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30
filingDate	2014-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d35c87ff6d60335e06b236e8250fd8f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de14d7323bf001d0241b56103c314bdc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b1d15871df1fed8db1de622872efde9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e78f7c0f0cda1daf56d25ac6a308b3d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68c88ef6f7588b016c763bd67fe8f836 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bddbb29ba9fdca6331dd8e89c441cd39
publicationDate	2015-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	PH-12014502325-A1
titleOfInvention	Sustained release tablet containing levodropropizine and method for preparing same
abstract	The present invention relates to a sustained release tablet of levodropropizine consisting of an immediate release layer, which includes levodropropizine, and a sustained release layer, which includes levodropropizine and a polymer for controlling release.
priorityDate	2012-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494059 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65859

Total number of triples: 31.